Core Laboratories Inc. witnessed a single insider purchase recently, as Chairman and CEO Bruno Lawrence acquired shares valued at $53,900 on July 31, 2026. This transaction followed the company's latest earnings report, which showed a 37.5% EPS beat. The stock has declined 10.5% over the past ninety days, currently trading near its fifty-two-week low.